Sruchika Sabu
Research Subjects
Research Interests
Sruchika Sabu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth S. Sandberg
Department of Pediatrics, Division of Endocrinology, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA
1 shared publication Hope Corman
Department of Economics, Rider University and National Bureau of Economic Research, Lawrenceville, New Jersey, United States of America
1 shared publicationKelly Noonan
Department of Economics, Princeton University, Princeton, New Jersey, United States of America
1 shared publicationKirsten B Kuhn
School of Public and International Affairs, Princeton University, Princeton, New Jersey, United States of America
1 shared publication- Kristen N. Lee
Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48109
1 shared publication - Mark Dulchavsky
Howard Hughes Medical Institute, University of Michigan, Ann Arbor, USA
1 shared publication
Latest Publications
- Open Access
- 5 July 2026
- Published by Elsevier in SSRN Electronic Journal
Hyperthyroidism-Associated Metabolic Decompensation in Maple Syrup Urine Disease
BackgroundMaple syrup urine disease (MSUD) is an inherited disorder of branched-chain amino acid metabolism in which metabolic decompensation is commonly triggered by catabolic stress. Hyperthyroidism has rarely been reported as a precipitant of hyperleucinosis in patients with MSUD, with only a single prior case identified in the literature.Case PresentationA 21-year-old man with classic MSUD and previously stable metabolic control developed persistent hyperleucinosis despite adherence to typical sick-day management and without an easily identifiable trigger. Following hospital admission for refractory hyperleucinosis, evaluation revealed thyrotoxicosis with suppressed thyroid-stimulating hormone and elevated free thyroxine. Further investigation demonstrated positive thyroid peroxidase antibodies and findings consistent with Hashitoxicosis secondary to Hashimoto’s thyroiditis. Because standard therapies for thyroiditis-associated thyrotoxicosis posed challenges in the setting of MSUD, treatment was initiated with cholestyramine and propranolol. Following treatment of thyrotoxicosis and continued metabolic support, plasma leucine concentrations declined rapidly and normalized after discharge. The patient subsequently transitioned to hypothyroidism and required levothyroxine replacement therapy.ConclusionThis case highlights thyrotoxicosis due to Hashimoto’s thyroiditis as a potentially underrecognized trigger of metabolic decompensation in MSUD and supports consideration of thyroid disease in patients with unexplained metabolic instability.
- 5 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHyperthyroidism-Associated Metabolic Decompensation in Maple Syrup Urine Disease
BackgroundMaple syrup urine disease (MSUD) is an inherited disorder of branched-chain amino acid metabolism in which metabolic decompensation is commonly triggered by catabolic stress. Hyperthyroidism has rarely been reported as a precipitant of hyperleucinosis in patients with MSUD, with only a single prior case identified in the literature.Case PresentationA 21-year-old man with classic MSUD and previously stable metabolic control developed persistent hyperleucinosis despite adherence to typical sick-day management and without an easily identifiable trigger. Following hospital admission for refractory hyperleucinosis, evaluation revealed thyrotoxicosis with suppressed thyroid-stimulating hormone and elevated free thyroxine. Further investigation demonstrated positive thyroid peroxidase antibodies and findings consistent with Hashitoxicosis secondary to Hashimoto’s thyroiditis. Because standard therapies for thyroiditis-associated thyrotoxicosis posed challenges in the setting of MSUD, treatment was initiated with cholestyramine and propranolol. Following treatment of thyrotoxicosis and continued metabolic support, plasma leucine concentrations declined rapidly and normalized after discharge. The patient subsequently transitioned to hypothyroidism and required levothyroxine replacement therapy.ConclusionThis case highlights thyrotoxicosis due to Hashimoto’s thyroiditis as a potentially underrecognized trigger of metabolic decompensation in MSUD and supports consideration of thyroid disease in patients with unexplained metabolic instability.
- Open Access
- 6 September 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0309363
Small for gestational age and age at menarche in a contemporary population-based U.S. sample
Children born small for gestational age (SGA) may be at risk for earlier puberty and adverse long-term health sequelae. This study investigates associations between SGA and age at menarche using secondary data on 1,027 female children in a population-based U.S. birth cohort that over-sampled non-marital births, which in the U.S. is a policy-relevant population. SGA was defined as th percentile of weight for gestational age compared to the national U.S. distribution. We estimated unadjusted and adjusted Ordinary Least Squares (OLS) models of associations between SGA and age at menarche in years, as well as unadjusted and adjusted logistic regression models of associations between SGA and early menarche (before age 11). SGA was not significantly associated with earlier age at menarche, even when adjusting for maternal sociodemographic characteristics, prenatal smoking, and maternal pre-pregnancy overweight and obesity. Similarly, SGA was not significantly associated with the odds of menarche occurring before age 11. However, maternal non-Hispanic Black race-ethnicity, Hispanic ethnicity, and pre-pregnancy obesity all had independent associations with average earlier age at menarche and menarche before age 11. Thus, maternal risk factors appear to play more influential roles in determining pubertal development.
- 6 September 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0309363
Open AccessSmall for gestational age and age at menarche in a contemporary population-based U.S. sample
Children born small for gestational age (SGA) may be at risk for earlier puberty and adverse long-term health sequelae. This study investigates associations between SGA and age at menarche using secondary data on 1,027 female children in a population-based U.S. birth cohort that over-sampled non-marital births, which in the U.S. is a policy-relevant population. SGA was defined as th percentile of weight for gestational age compared to the national U.S. distribution. We estimated unadjusted and adjusted Ordinary Least Squares (OLS) models of associations between SGA and age at menarche in years, as well as unadjusted and adjusted logistic regression models of associations between SGA and early menarche (before age 11). SGA was not significantly associated with earlier age at menarche, even when adjusting for maternal sociodemographic characteristics, prenatal smoking, and maternal pre-pregnancy overweight and obesity. Similarly, SGA was not significantly associated with the odds of menarche occurring before age 11. However, maternal non-Hispanic Black race-ethnicity, Hispanic ethnicity, and pre-pregnancy obesity all had independent associations with average earlier age at menarche and menarche before age 11. Thus, maternal risk factors appear to play more influential roles in determining pubertal development.